Cardiovascular deaths 12 percent less likely if have 10 ng more vitamin D – meta-analysis

Created March 2017

Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies.

Am J Clin Nutr. 2017 Mar 1. pii: ajcn140392. doi: 10.3945/ajcn.116.140392. [Epub ahead of print]

Zhang R1,2,3,4, Li B1, Gao X5, Tian R1, Pan Y1,2,3,4, Jiang Y1,2,3,4, Gu H1,2,3,4, Wang Y1,2,3,4, Wang Y1,2,3,4, Liu G6,2,3,4.

1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

2China National Clinical Research Center for Neurological Diseases, Beijing, China.

3Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China.

4Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China; 5Department of Nutritional Sciences, Pennsylvania State University, State College, PA.

6Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; [email protected].

25% less risk of dying of CVD with high level of Vitamin D

image

Based on many studies, Vitamin D Life suspects a 60% reduction in CVD mortality in those having

  • Enough Vitamin D

  • Enough Magnesium

  • Enough Omega-3

  • Enough Vitamin K2

  • Reduced Calcium

1. For every 10 nanogram/mL higher vitamin D 10% less likely to have CVD Events 12% less likely to have CVD deathCardiovascular category listing has items along with related searchesThe Meta-analyses of Cardiovascular and Vitamin D{category}Vitamin D Intervention AND Cardiovascular studies{category}Cardiovascular category starts with the following {include}Studies in all 3 categories: Cardiovascular, Meta-analysis and Mortality{category}Pages listed in BOTH the categories Mortality and Cardiovascular{category}

Background: During the past decade, an increasing number of prospective studies have focused on the association between vitamin D and cardiovascular disease (CVD). However, the evidence on the relation between serum 25-hydroxyvitamin D [25(OH)D] and the risk of overt CVD is inconclusive.

Objective: We performed a dose-response meta-analysis to summarize and prospectively quantify the RR of low serum 25(OH)D concentration and total CVD (events and mortality).

Design: We identified relevant studies by searching PubMed and EMBASE up to December 2015 and by hand-searching reference lists. Prospective studies based on the general population and reported RRs and 95% CIs were included. A random-effects model was used to calculate the pooled RRs. Nonlinear association was assessed by using restricted cubic spline analyses.

Results: A total of 34 publications with 180,667 participants were eligible for the meta-analysis. We included 32 publications (27 independent studies) for total CVD events and 17 publications (17 independent studies) for CVD mortality. We observed an inverse association between serum 25(OH)D and total CVD events and CVD mortality, and the pooled RRs per 10-ng/mL increment were 0.90 (95% CI: 0.86, 0.94) for total CVD events and 0.88 (95% CI: 0.80, 0.96) for CVD mortality. A nonlinear association was detected for total CVD events (P-nonlinear < 0.001) and CVD mortality (P-nonlinear = 0.022).

Conclusion: Serum 25(OH)D concentration was inversely associated with total CVD events and CVD mortality from the observed studies.

© 2017 American Society for Nutrition. Publisher rents this PDF as well as all other PDFs for a total of $25

PMID: 28251933 DOI: 10.3945/ajcn.116.140392

Tags: Cardiovascular Meta-analysis Mortality